Food/Recall·FDA Recalls, Market Withdrawals & Safety Alerts

HH Fresh Trading. Recalls TW Enoki Mushrooms 150g Because of Possible Health Risk

HighPublished May 13, 2026· AI-analyzed May 14, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

HH Fresh Trading is recalling 120 cases of Enoki Mushroom 150g due to potential contamination with Listeria monocytogenes.

Who it affects

This recall affects HH Fresh Trading, food distributors in the Los Angeles area, and quality assurance professionals responsible for produce safety and microbiological monitoring.

Why it matters

The presence of Listeria monocytogenes in fresh produce represents a significant clinical risk to vulnerable populations, including children and the elderly. From a regulatory standpoint, this indicates a potential breakdown in environmental monitoring or supplier verification programs. Failure to address this could lead to further enforcement actions or expanded recalls if the contamination source is not isolated.

Practical takeaway

QA teams should verify that all 120 cases of the specified 150g TW Enoki Mushrooms are identified, quarantined, and removed from distribution. Supply chain managers should investigate the source of the potential contamination and audit sanitation protocols at the point of origin.

FDA source material

HH Fresh Trading of Los Angeles, California State is recalling 120 cases of Enoki Mushroom 150g, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.